Vipul Sitaram Thakkar

Vipul Sitaram Thakkar is a prominent inventor based in Ahmedabad, India. He has made significant contributions to the field of cancer research, particularly in the development of innovative treatments targeting cancer cells. His work focuses on understanding the immune response to cancer and how it can be harnessed for therapeutic purposes.

Latest Patents

Thakkar holds a patent related to cancer antigens. The patent describes a method where cancer cells treated with cisplatin, paclitaxel, gemcitabine, or a combination of these agents exhibit an altered protein profile. This altered protein profile includes at least one protein that is commonly expressed or overexpressed. The identified protein induces an immune response that is specific to cancer cells, while remaining non-reactive to normal cells and different tissues or organs of origin.

Career Highlights

Thakkar is currently associated with Cadila Pharmaceuticals Limited, a leading pharmaceutical company in India. His work at Cadila Pharmaceuticals focuses on advancing cancer treatment options and improving patient outcomes through innovative research.

Collaborations

Thakkar has collaborated with notable colleagues in his field, including Indravadan Ambalal Modi and Bakulesh Mafatlal Khamar. These collaborations have further enhanced his research and contributed to the development of effective cancer therapies.

Conclusion

Vipul Sitaram Thakkar's contributions to cancer research and his innovative patent highlight his commitment to improving cancer treatment. His work continues to inspire advancements in the medical field, making a significant impact on patient care.

Profile summary based on public USPTO records.